| ViraEpi1401 | Epstein barr virus (EBV) | Cp | NA | 11045 | 11045 | Intermediate | 50% | HD tumor sample 3 | Tumor from untreated patient | 6 clones | Hodgkin disease (HD) | Bisulphite PCR | 8874213 | | ViraEpi1476 | Epstein barr virus (EBV) | Cp | NA | 10608 | 10608 | Intermediate | 50-75% | Cell line | Rael cell line | NA | NA | Bisulfite seq | 19264589 | | ViraEpi1495 | Epstein barr virus (EBV) | Cp | NA | 10379 | 10379 | Intermediate | 50-75% | Cell line | Raji cell line | NA | NA | Bisulfite seq | 19264589 | | ViraEpi1569 | Epstein barr virus (EBV) | Cp | NA | 10490 | 10490 | Intermediate | 50-75% | Cell line | C666-1 cell line | NA | NA | Bisulfite seq | 19264589 | | ViraEpi1570 | Epstein barr virus (EBV) | Cp | NA | 10547 | 10547 | Intermediate | 50-75% | Cell line | C666-1 cell line | NA | NA | Bisulfite seq | 19264589 | | ViraEpi1600 | Epstein barr virus (EBV) | Cp | NA | 10570 | 10570 | IntermedIate | 50-75% | Cell line | NPC-C18 cell line | NA | NA | Bisulfite seq | 19264589 | | ViraEpi1621 | Epstein barr virus (EBV) | Cp | NA | 10865 | 10865 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1622 | Epstein barr virus (EBV) | Cp | NA | 10955 | 10955 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1623 | Epstein barr virus (EBV) | Cp | NA | 10958 | 10958 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1624 | Epstein barr virus (EBV) | Cp | NA | 10984 | 10984 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1625 | Epstein barr virus (EBV) | Cp | NA | 10987 | 10987 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1626 | Epstein barr virus (EBV) | Cp | NA | 11029 | 11029 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1627 | Epstein barr virus (EBV) | Cp | NA | 11044 | 11044 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1628 | Epstein barr virus (EBV) | Cp | NA | 11062 | 11062 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1629 | Epstein barr virus (EBV) | Cp | NA | 11065 | 11065 | IntermedIate | 60% | Normal donor | PBMC from normal donor 3 | 5 clones | NA | Bisulfite seq | 9373258 | | ViraEpi1647 | Epstein barr virus (EBV) | DS | NA | 9032 | 9032 | Intermediate | 57.14% | Cell line | Rael cell line (BL type I) | 7 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1657 | Epstein barr virus (EBV) | LRS | NA | 169425 | 169425 | Intermediate | > 40% and < 60% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1663 | Epstein barr virus (EBV) | LRS | NA | 169567 | 169567 | Intermediate | > 40% and < 60% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 | | ViraEpi1678 | Epstein barr virus (EBV) | LRS | NA | 22 | 22 | Intermediate | > 40% and < 60% | Cell line | Rael cell line (BL type I) | 3-6 clones | Burkitt Lymphoma (BL) | Bisulfite seq | 9525618 |